orotate
Summary
Orotate (orotic acid) is an intermediate in de novo pyrimidine synthesis, formed from dihydroorotate by dihydroorotate dehydrogenase and converted to OMP by UMP synthase (orotate phosphoribosyltransferase). Accumulates and is excreted in urine in orotic aciduria (UMP synthase deficiency) and in OTC deficiency (where excess carbamoyl phosphate spills into the pyrimidine pathway).
Detail
**Pathway (de novo pyrimidine synthesis):** Glutamine + CO2 + 2 ATP → carbamoyl phosphate (CPS II, cytosolic; rate-limiting; inhibited by UTP, activated by PRPP) → + aspartate → carbamoyl aspartate (aspartate transcarbamoylase) → dihydroorotate (dihydroorotase) → **orotate** (dihydroorotate dehydrogenase, mitochondrial inner membrane; inhibited by leflunomide and teriflunomide) → orotidine-5'-monophosphate (OMP) (orotate phosphoribosyltransferase, uses PRPP) → UMP (OMP decarboxylase). The last two steps are catalyzed by the bifunctional enzyme **UMP synthase**.
**Hereditary orotic aciduria:** - Autosomal recessive UMP synthase deficiency. - Presents in infancy with megaloblastic anemia that does not respond to B12 or folate, failure to thrive, developmental delay, and orotic acid crystals in the urine. - There is no hyperammonemia, which distinguishes it from OTC deficiency. - Treatment is oral uridine (or triacetyluridine), which bypasses the block and also provides negative feedback by inhibiting CPS II.
**OTC deficiency (X-linked recessive urea cycle disorder):** - Carbamoyl phosphate accumulates in mitochondria and spills into the cytosol, where it enters the pyrimidine pathway. This increases orotic acid. - Findings: hyperammonemia, increased orotic acid in blood and urine, decreased BUN, and neurologic symptoms (lethargy, vomiting, cerebral edema), often after protein intake. - Treatment: low-protein diet, nitrogen scavengers (sodium benzoate, phenylbutyrate), and arginine or citrulline in some cases.
**Differentiating high orotic acid:** - Orotic aciduria: megaloblastic anemia, normal ammonia, normal BUN. - OTC deficiency: high ammonia, low BUN, no megaloblastic anemia.
**Other associations:** - Allopurinol and other drugs that inhibit OMP decarboxylase can raise orotate or orotidine levels. This is a classic test-writer link between purine and pyrimidine metabolism. - Leflunomide inhibits dihydroorotate dehydrogenase, which blocks pyrimidine synthesis in rapidly dividing lymphocytes (used in RA). - Mnemonic: with orotic aciduria, "no hyperammonemia."
Sources
- First Aid for the USMLE Step 1 (Biochemistry: Nucleotide synthesis, Urea cycle)
- Lippincott Illustrated Reviews: Biochemistry (Nucleotide metabolism)
- Harper's Illustrated Biochemistry
- Pathoma / Sketchy Medical (Biochemistry: Pyrimidine synthesis)
- Robbins & Cotran Pathologic Basis of Disease (Inherited metabolic disorders)
Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.